Loading BMY...
Bristol Myers Squibb CoBMYAs of 31 July 2026
−300−1500+150+300
+107
PositiveNegative
Negative skew
CheapExpensive
FearGreed
WeakStrong
Asymmetry

Is Bristol Myers Squibb Co a good buy right now?

Whether Bristol Myers Squibb Co (BMY) looks like a good buy comes down to three things: how it is valued, how the market feels about it, and how strong the underlying business is. Each is measured against Bristol Myers Squibb Co's own five-year history, so you see genuine dislocation rather than noise. Information, not advice.

Bristol Myers Squibb CoBMYLast 5 years
VEFA
BMY priceasymmetryquant.com